Print

Purpose

The goal of this observational study is to better understand links between patient or tumor characteristics and outcomes in HER2-positive breast cancer.

Condition

Eligibility

Eligible Ages
Over 18 Years
Eligible Genders
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • Stage I-IV HER2-positive breast cancer

Exclusion Criteria

  • None

Study Design

Phase
Study Type
Observational [Patient Registry]
Observational Model
Cohort
Time Perspective
Prospective

Arm Groups

ArmDescriptionAssigned Intervention
HER2-positive breast cancer Patients with stage I-IV HER2-positive breast cancer

Recruiting Locations

The University of Kansas Cancer Center
Westwood, Kansas 66205
Contact:
Program Director
913-588-6079
PRO-HER2@kumc.edu

More Details

Status
Recruiting
Sponsor
Priyanka Sharma

Study Contact

Study Coordinator
913-588-6079
PRO-HER2@kumc.edu

Notice

Study information shown on this site is derived from ClinicalTrials.gov (a public registry operated by the National Institutes of Health). The listing of studies provided is not certain to be all studies for which you might be eligible. Furthermore, study eligibility requirements can be difficult to understand and may change over time, so it is wise to speak with your medical care provider and individual research study teams when making decisions related to participation.